These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 94617)

  • 41. Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases.
    Von Hoff DD; Rozencweig M; Layard M; Slavik M; Muggia FM
    Am J Med; 1977 Feb; 62(2):200-8. PubMed ID: 835599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Editorial: Adriamycin and the heart.
    Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302
    [No Abstract]   [Full Text] [Related]  

  • 43. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
    Morgan RJ; Doroshow JH; Venkataraman K; Chang K; Raschko J; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Margolin K; Forman S; Akman S; Coluzzi P; Ahn C; Weiss L; Gadgil U; Harrison J
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2337-45. PubMed ID: 9815632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective study of cardiomyopathy induced by adjuvant doxorubicin therapy in patients with soft-tissue sarcomas.
    Ettinghausen SE; Bonow RO; Palmeri ST; Seipp CA; Steinberg SM; White DE; Rosenberg SA
    Arch Surg; 1986 Dec; 121(12):1445-51. PubMed ID: 3789915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H; Toyota S; Takahara O; Ichimaru M
    Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
    [No Abstract]   [Full Text] [Related]  

  • 46. Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.
    Hausdorf G; Morf G; Beron G; Erttmann R; Winkler K; Landbeck G; Keck EW
    Br Heart J; 1988 Oct; 60(4):309-15. PubMed ID: 3190959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients.
    Hutchinson RJ; Bailey C; Wood D; Donaldson MH
    Cancer Treat Rep; 1978 Jun; 62(6):907-10. PubMed ID: 667866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation.
    Zambetti M; Moliterni A; Materazzo C; Stefanelli M; Cipriani S; Valagussa P; Bonadonna G; Gianni L
    J Clin Oncol; 2001 Jan; 19(1):37-43. PubMed ID: 11134193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of early anthracycline-induced cardiotoxicity in childhood cancer with dobutamine stress echocardiography.
    Lenk MK; Zeybek C; Okutan V; Ozcan O; Gökçay E
    Turk J Pediatr; 1998; 40(3):373-83. PubMed ID: 9763901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.
    Uyar D; Kulp B; Peterson G; Zanotti K; Markman M; Belinson J
    Gynecol Oncol; 2004 Jul; 94(1):147-51. PubMed ID: 15262133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac safety profile of pegylated liposomal doxorubicin reaching or exceeding lifetime cumulative doses of 550 mg/m2 in patients with recurrent ovarian and peritoneal cancer.
    Yildirim Y; Gultekin E; Avci ME; Inal MM; Yunus S; Tinar S
    Int J Gynecol Cancer; 2008; 18(2):223-7. PubMed ID: 17511800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anthracycline cardiotoxicity and acute myelogenous leukaemia.
    Al-Ismail SA; Parry DH; Whittaker JA
    Br Med J; 1977 Mar; 1(6064):815. PubMed ID: 265741
    [No Abstract]   [Full Text] [Related]  

  • 53. Late effects of anthracycline therapy in childhood on signal-averaged ECG parameters.
    Mladosievicova B; Foltinova A; Petrasova H; Hulin I
    Int J Mol Med; 2000 Apr; 5(4):411-4. PubMed ID: 10719059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide.
    Kolaric K; Bradamante V; Cervek J; Cieslinska A; Cisarz-Filipcak E; Denisov LE; Donat D; Drosik K; Gershanovic M; Hudziec P
    Oncology; 1995; 52(3):251-5. PubMed ID: 7715910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
    Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.
    Trouet A; Sokal G
    Cancer Treat Rep; 1979 May; 63(5):895-8. PubMed ID: 287556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.
    Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C
    Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Echocardiographic assessment of anthracycline cardiotoxicity in children.
    Lewis AB; Pilkington R; Takahashi M; Siegel SE
    Med Pediatr Oncol; 1978; 5(1):167-75. PubMed ID: 745585
    [No Abstract]   [Full Text] [Related]  

  • 59. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer.
    Speyer JL; Green MD; Kramer E; Rey M; Sanger J; Ward C; Dubin N; Ferrans V; Stecy P; Zeleniuch-Jacquotte A
    N Engl J Med; 1988 Sep; 319(12):745-52. PubMed ID: 3137469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overview of cardiac pathology in relation to anthracycline cardiotoxicity.
    Ferrans VJ
    Cancer Treat Rep; 1978 Jun; 62(6):955-61. PubMed ID: 352510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.